Arrowstreet Capital Limited Partnership Acquires 186,880 Shares of Cigna Group $CI

Arrowstreet Capital Limited Partnership boosted its holdings in Cigna Group (NYSE:CI) by 7.4% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,695,620 shares of the health services provider’s stock after buying an additional 186,880 shares during the quarter. Arrowstreet Capital Limited Partnership owned approximately 1.01% of Cigna Group worth $777,012,000 at the end of the most recent reporting period.

Several other institutional investors have also recently bought and sold shares of CI. Norges Bank bought a new position in Cigna Group in the 2nd quarter valued at approximately $1,110,426,000. Capital Research Global Investors grew its stake in shares of Cigna Group by 140.2% during the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock worth $916,434,000 after buying an additional 1,855,897 shares during the last quarter. Balyasny Asset Management L.P. increased its holdings in shares of Cigna Group by 1,057.2% during the second quarter. Balyasny Asset Management L.P. now owns 404,753 shares of the health services provider’s stock worth $133,803,000 after buying an additional 369,775 shares in the last quarter. Man Group plc lifted its stake in shares of Cigna Group by 215.5% in the 2nd quarter. Man Group plc now owns 532,183 shares of the health services provider’s stock valued at $175,929,000 after acquiring an additional 363,510 shares during the last quarter. Finally, Corient Private Wealth LLC lifted its stake in shares of Cigna Group by 257.4% in the 2nd quarter. Corient Private Wealth LLC now owns 389,637 shares of the health services provider’s stock valued at $127,811,000 after acquiring an additional 280,616 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Buying and Selling at Cigna Group

In related news, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the transaction, the insider owned 32,647 shares of the company’s stock, valued at $9,432,044.77. This trade represents a 6.60% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider owned 5,670 shares in the company, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

CI has been the topic of a number of research reports. Mizuho set a $325.00 price objective on Cigna Group in a research report on Friday, January 9th. Sanford C. Bernstein raised Cigna Group from a “market perform” rating to an “outperform” rating and lifted their price target for the company from $307.00 to $358.00 in a research note on Thursday. Barclays reduced their price target on Cigna Group from $305.00 to $303.00 and set an “overweight” rating on the stock in a report on Friday, February 6th. Royal Bank Of Canada dropped their price objective on shares of Cigna Group from $344.00 to $333.00 and set an “outperform” rating for the company in a report on Friday, February 6th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on shares of Cigna Group from $301.00 to $304.00 and gave the stock a “buy” rating in a research report on Tuesday, February 10th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, Cigna Group presently has a consensus rating of “Moderate Buy” and an average target price of $333.11.

Cigna Group Trading Up 2.1%

Shares of CI stock opened at $266.41 on Friday. Cigna Group has a 1-year low of $239.51 and a 1-year high of $350.00. The company has a current ratio of 0.74, a quick ratio of 0.74 and a debt-to-equity ratio of 0.74. The stock has a market cap of $70.21 billion, a price-to-earnings ratio of 12.01, a PEG ratio of 0.90 and a beta of 0.27. The stock has a 50-day moving average of $279.83 and a 200-day moving average of $283.17.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. The company had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The firm’s quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the firm earned $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, equities research analysts forecast that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be given a dividend of $1.56 per share. This represents a $6.24 annualized dividend and a dividend yield of 2.3%. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date is Thursday, March 5th. Cigna Group’s dividend payout ratio is currently 28.13%.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.